Brief: DiaCarta Announces Successful Completion Of Oncuria Validation Study With Nonagen Bioscience
05/01/2023 14:03
Jan 5 (Reuters) - DiaCarta Inc :
* DIACARTA ANNOUNCES SUCCESSFUL COMPLETION OF ONCURIA®
VALIDATION
STUDY WITH NONAGEN BIOSCIENCE
Source text for Eikon: ID:nGNX1wFhmD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HH&L Acquisition Co
See all newsBrief: Hh&L Acquisition Co says It Will Redeem All Of Its Outstanding Ordinary Shares That Were Included In Units Issued In Its IPO
Brief: DiaCarta Announces The Termination Of Business Combination Agreement With HH&L Acquisition Co
Brief: Hh&L Acquisition Co Says On June 26, Hh&L Sent Diacarta Ltd., Termination Notice That Hh&L Had Terminated Business Combination Agreement
HHLA calls for final approval of China's Cosco investment in Hamburg port (updated)
Germany's HHLA expects quick feedback from Econ Ministry on Cosco acquisition